Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Contrasting, species-dependent modulation of copper-mediated neurotoxicity by the Alzheimer's disease amyloid precursor protein.
White AR
,
Multhaup G
,
Galatis D
,
McKinstry WJ
,
Parker MW
,
Pipkorn R
,
Beyreuther K
,
Masters CL
,
Cappai R
.
???displayArticle.abstract???
The amyloid precursor protein (APP) of Alzheimer's disease (AD) has a copper binding domain (CuBD) located in the N-terminal cysteine-rich region that can strongly bind copper(II) and reduce it to Cu(I) in vitro. The CuBD sequence is similar among the APP family paralogs [amyloid precursor-like proteins (APLP1 and APLP2)] and its orthologs (including Drosophila melanogaster, Xenopus laevis, and Caenorhabditis elegans), suggesting an overall conservation in its function or activity. The APP CuBD is involved in modulating Cu homeostasis and amyloid beta peptide production. In this paper, we demonstrate for the first time that Cu-metallated full-length APP ectodomain induces neuronal cell death in vitro. APP Cu neurotoxicity can be induced directly or potentiated through Cu(I)-mediated oxidation of low-density lipoprotein, a finding that may have important implications for the role of lipoproteins and membrane cholesterol composition in AD. Cu toxicity induced by human APP, Xenopus APP, and APLP2 CuBDs is dependent on conservation of histidine residues at positions corresponding to 147 and 151 of human APP. Intriguingly, APP orthologs with different amino acid residues at these positions had dramatically altered Cu phenotypes. The corresponding C. elegans APL-1 CuBD, which has tyrosine and lysine residues at positions 147 and 151, respectively, strongly protected against Cu-mediated lipid peroxidation and neurotoxicity in vitro. Replacement of histidines 147 and 151 with tyrosine and lysine residues conferred this neuroprotective Cu phenotype to human APP, APLP2, and Xenopus APP CuBD peptides. Moreover, we show that the toxic and protective CuBD phenotypes are associated with differences in Cu binding and reduction. These studies identify a significant evolutionary change in the function of the CuBD in modulating Cu metabolism. Our findings also suggest that targeting of inhibitors to histidine residues at positions 147 and 151 of APP could significantly alter the oxidative potential of APP.
Andrews,
Mining copper transport genes.
2001, Pubmed
Andrews,
Mining copper transport genes.
2001,
Pubmed
Atwood,
Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis.
1998,
Pubmed
Azzouz,
Prevention of mutant SOD1 motoneuron degeneration by copper chelators in vitro.
2000,
Pubmed
Bassett,
Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo.
1999,
Pubmed
Bassett,
Cerebrospinal fluid lipoproteins in Alzheimer's disease.
2000,
Pubmed
Borchardt,
Differential effects of zinc on amyloid precursor protein (APP) processing in copper-resistant variants of cultured Chinese hamster ovary cells.
2000,
Pubmed
Borchardt,
Copper inhibits beta-amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion.
1999,
Pubmed
Bush,
Metals and neuroscience.
2000,
Pubmed
Cappai,
Recombinant human amyloid precursor-like protein 2 (APLP2) expressed in the yeast Pichia pastoris can stimulate neurite outgrowth.
1999,
Pubmed
Cherny,
Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion.
1999,
Pubmed
Coulson,
What the evolution of the amyloid protein precursor supergene family tells us about its function.
2000,
Pubmed
DOBBINGJ,
THE ENTRY OF CHOLESTEROL INTO RAT BRAIN DURING DEVELOPMENT.
1963,
Pubmed
Daigle,
apl-1, a Caenorhabditis elegans gene encoding a protein related to the human beta-amyloid protein precursor.
1993,
Pubmed
Georgatsou,
The yeast Fre1p/Fre2p cupric reductases facilitate copper uptake and are regulated by the copper-modulated Mac1p activator.
1997,
Pubmed
Glenner,
Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein.
1984,
Pubmed
Hardy,
Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau.
1998,
Pubmed
Harr,
Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease.
1996,
Pubmed
Hassett,
Evidence for Cu(II) reduction as a component of copper uptake by Saccharomyces cerevisiae.
1995,
Pubmed
Henry,
Expression of human amyloid precursor protein ectodomains in Pichia pastoris: analysis of culture conditions, purification, and characterization.
1997,
Pubmed
Henry,
Inhibition of platelet activation by the Alzheimer's disease amyloid precursor protein.
1998,
Pubmed
Hesse,
The beta A4 amyloid precursor protein binding to copper.
1994,
Pubmed
Howland,
Modulation of secreted beta-amyloid precursor protein and amyloid beta-peptide in brain by cholesterol.
1998,
Pubmed
Huang,
Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction.
1999,
Pubmed
Huang,
The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction.
1999,
Pubmed
Iijima,
cDNA isolation of Alzheimer's amyloid precursor protein from cholinergic nerve terminals of the electric organ of the electric ray.
1998,
Pubmed
Kabara,
A critical review of brain cholesterol metabolism.
1973,
Pubmed
Kang,
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor.
,
Pubmed
Keller,
Oxidized low-density lipoprotein induces neuronal death: implications for calcium, reactive oxygen species, and caspases.
1999,
Pubmed
Keller,
Oxidized high-density lipoprotein induces neuron death.
2000,
Pubmed
Koh,
Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage.
1990,
Pubmed
Lovell,
Copper, iron and zinc in Alzheimer's disease senile plaques.
1998,
Pubmed
Markesbery,
Oxidative stress hypothesis in Alzheimer's disease.
1997,
Pubmed
Martins,
Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress.
1986,
Pubmed
Masters,
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
1985,
Pubmed
Mattson,
Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein.
1993,
Pubmed
Melchor,
Fibrillar amyloid beta-protein mediates the pathologic accumulation of its secreted precursor in human cerebrovascular smooth muscle cells.
2000,
Pubmed
Milward,
The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth.
1992,
Pubmed
Moir,
Human brain beta A4 amyloid protein precursor of Alzheimer's disease: purification and partial characterization.
1992,
Pubmed
Multhaup,
Copper-binding amyloid precursor protein undergoes a site-specific fragmentation in the reduction of hydrogen peroxide.
1998,
Pubmed
Multhaup,
The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I).
1996,
Pubmed
Okado,
Developmental regulation of Xenopus beta-amyloid precursor protein gene expression.
1995,
Pubmed
,
Xenbase
Pitas,
Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain.
1987,
Pubmed
Praticò,
Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis.
2001,
Pubmed
Rae,
Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase.
1999,
Pubmed
Rossjohn,
Crystal structure of the N-terminal, growth factor-like domain of Alzheimer amyloid precursor protein.
1999,
Pubmed
Ruiz,
Cysteine 144 is a key residue in the copper reduction by the beta-amyloid precursor protein.
1999,
Pubmed
Sambongi,
Sensing of cadmium and copper ions by externally exposed ADL, ASE, and ASH neurons elicits avoidance response in Caenorhabditis elegans.
1999,
Pubmed
Sayre,
In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals.
2000,
Pubmed
Schippling,
Increased lipoprotein oxidation in Alzheimer's disease.
2000,
Pubmed
Schmitt,
Amyloid beta-protein(25-35) increases cellular APP and inhibits the secretion of APPs in human extraneuronal cells.
1997,
Pubmed
Slunt,
Expression of a ubiquitous, cross-reactive homologue of the mouse beta-amyloid precursor protein (APP).
1994,
Pubmed
Small,
A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth.
1994,
Pubmed
Smith,
Iron accumulation in Alzheimer disease is a source of redox-generated free radicals.
1997,
Pubmed
Storey,
Amyloid precursor protein of Alzheimer's disease: evidence for a stable, full-length, trans-membrane pool in primary neuronal cultures.
1999,
Pubmed
Torroja,
APPL, the Drosophila member of the APP-family, exhibits differential trafficking and processing in CNS neurons.
1996,
Pubmed
Villard,
Analysis of pufferfish homologues of the AT-rich human APP gene.
1998,
Pubmed
Waggoner,
The role of copper in neurodegenerative disease.
1999,
Pubmed
Wasco,
Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer disease-associated amyloid beta protein precursor.
1992,
Pubmed
White,
The Alzheimer's disease amyloid precursor protein modulates copper-induced toxicity and oxidative stress in primary neuronal cultures.
1999,
Pubmed
White,
Survival of cultured neurons from amyloid precursor protein knock-out mice against Alzheimer's amyloid-beta toxicity and oxidative stress.
1998,
Pubmed
White,
Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice.
1999,
Pubmed
Yamada,
Further characterization of a monoclonal antibody recognizing apolipoprotein E peptides in amyloid deposits.
1997,
Pubmed
Yankner,
Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.
1990,
Pubmed
Yim,
A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: An enhancement of free radical formation due to a decrease in Km for hydrogen peroxide.
1996,
Pubmed
